These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 26341632

  • 1. Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes.
    Monnier VM, Sun W, Gao X, Sell DR, Cleary PA, Lachin JM, Genuth S, DCCT/EDIC Research Group.
    Cardiovasc Diabetol; 2015 Sep 05; 14():118. PubMed ID: 26341632
    [Abstract] [Full Text] [Related]

  • 2. Skin collagen fluorophore LW-1 versus skin fluorescence as markers for the long-term progression of subclinical macrovascular disease in type 1 diabetes.
    Sell DR, Sun W, Gao X, Strauch C, Lachin JM, Cleary PA, Genuth S, DCCT/EDIC Research Group, Monnier VM.
    Cardiovasc Diabetol; 2016 Feb 11; 15():30. PubMed ID: 26864236
    [Abstract] [Full Text] [Related]

  • 3. The pecking order of skin Advanced Glycation Endproducts (AGEs) as long-term markers of glycemic damage and risk factors for micro- and subclinical macrovascular disease progression in Type 1 diabetes.
    Monnier VM, Genuth S, Sell DR.
    Glycoconj J; 2016 Aug 11; 33(4):569-79. PubMed ID: 27342131
    [Abstract] [Full Text] [Related]

  • 4. Skin advanced glycation end products glucosepane and methylglyoxal hydroimidazolone are independently associated with long-term microvascular complication progression of type 1 diabetes.
    Genuth S, Sun W, Cleary P, Gao X, Sell DR, Lachin J, DCCT/EDIC Research Group, Monnier VM.
    Diabetes; 2015 Jan 11; 64(1):266-78. PubMed ID: 25187362
    [Abstract] [Full Text] [Related]

  • 5. The association between skin collagen glucosepane and past progression of microvascular and neuropathic complications in type 1 diabetes.
    Monnier VM, Sell DR, Strauch C, Sun W, Lachin JM, Cleary PA, Genuth S, DCCT Research Group.
    J Diabetes Complications; 2013 Jan 11; 27(2):141-9. PubMed ID: 23153673
    [Abstract] [Full Text] [Related]

  • 6. Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes.
    Genuth S, Sun W, Cleary P, Sell DR, Dahms W, Malone J, Sivitz W, Monnier VM, DCCT Skin Collagen Ancillary Study Group.
    Diabetes; 2005 Nov 11; 54(11):3103-11. PubMed ID: 16249432
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Skin collagen pentosidine and fluorescence in diabetes were predictors of retinopathy progression and creatininemia increase already 6years after punch-biopsy.
    Sternberg M, M'bemba J, Urios P, Borsos AM, Selam JL, Peyroux J, Slama G.
    Clin Biochem; 2016 Feb 11; 49(3):225-31. PubMed ID: 26506116
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Control and Complications Trial.
    Monnier VM, Bautista O, Kenny D, Sell DR, Fogarty J, Dahms W, Cleary PA, Lachin J, Genuth S.
    Diabetes; 1999 Apr 11; 48(4):870-80. PubMed ID: 10102706
    [Abstract] [Full Text] [Related]

  • 11. Two fluorescent wavelengths, 440(ex)/520(em) nm and 370(ex)/440(em) nm, reflect advanced glycation and oxidation end products in human skin without diabetes.
    Beisswenger PJ, Howell S, Mackenzie T, Corstjens H, Muizzuddin N, Matsui MS.
    Diabetes Technol Ther; 2012 Mar 11; 14(3):285-92. PubMed ID: 22023375
    [Abstract] [Full Text] [Related]

  • 12. Skin autofluorescence associates with vascular calcification in chronic kidney disease.
    Wang AY, Wong CK, Yau YY, Wong S, Chan IH, Lam CW.
    Arterioscler Thromb Vasc Biol; 2014 Aug 11; 34(8):1784-90. PubMed ID: 24876353
    [Abstract] [Full Text] [Related]

  • 13. Serum endogenous secretory RAGE level is an independent risk factor for the progression of carotid atherosclerosis in type 1 diabetes.
    Katakami N, Matsuhisa M, Kaneto H, Matsuoka TA, Sakamoto K, Yasuda T, Umayahara Y, Kosugi K, Yamasaki Y.
    Atherosclerosis; 2009 May 11; 204(1):288-92. PubMed ID: 18926539
    [Abstract] [Full Text] [Related]

  • 14. Coronary Artery Disease Events and Carotid Intima-Media Thickness in Type 1 Diabetes in the DCCT/EDIC Cohort.
    Polak JF, Backlund JC, Budoff M, Raskin P, Bebu I, Lachin JM, DCCT/EDIC Research Group.
    J Am Heart Assoc; 2021 Dec 21; 10(24):e022922. PubMed ID: 34873921
    [Abstract] [Full Text] [Related]

  • 15. The effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) study.
    Purnell JQ, Zinman B, Brunzell JD, DCCT/EDIC Research Group.
    Circulation; 2013 Jan 15; 127(2):180-7. PubMed ID: 23212717
    [Abstract] [Full Text] [Related]

  • 16. High serum pentosidine concentrations are associated with increased arterial stiffness and thickness in patients with type 2 diabetes.
    Yoshida N, Okumura K, Aso Y.
    Metabolism; 2005 Mar 15; 54(3):345-50. PubMed ID: 15736112
    [Abstract] [Full Text] [Related]

  • 17. Non-invasive Measurement of Skin Autofluorescence as a Beneficial Surrogate Marker for Atherosclerosis in Patients with Type 2 Diabetes.
    Temma J, Matsuhisa M, Horie T, Kuroda A, Mori H, Tamaki M, Endo I, Aihara K, Abe M, Matsumoto T.
    J Med Invest; 2015 Mar 15; 62(3-4):126-9. PubMed ID: 26399335
    [Abstract] [Full Text] [Related]

  • 18. Subclinical Vascular Disease and Subsequent Erectile Dysfunction: The Multiethnic Study of Atherosclerosis (MESA).
    Feldman DI, Cainzos-Achirica M, Billups KL, DeFilippis AP, Chitaley K, Greenland P, Stein JH, Budoff MJ, Dardari Z, Miner M, Blumenthal RS, Nasir K, Blaha MJ.
    Clin Cardiol; 2016 May 15; 39(5):291-8. PubMed ID: 27145089
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Progression of carotid artery intima-media thickness during 12 years in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study.
    Polak JF, Backlund JY, Cleary PA, Harrington AP, O'Leary DH, Lachin JM, Nathan DM, DCCT/EDIC Research Group.
    Diabetes; 2011 Feb 15; 60(2):607-13. PubMed ID: 21270271
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.